Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
1don MSN
Eli Lilly released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly ...
If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...
Drugmaker Merck said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government ...
Coverage under Medicare remains prohibited while most large employer firms still do not cover GLP-1 drugs for weight loss. From 2019 to 2023, the number of GLP-1 prescriptions increased by more ...
The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans with Medicare and Medicaid. A shortage in injections linked to weight ...
Medicare Part D spending for 10 selected diabetes drugs totaled more than $35.8 billion in 2023, a 364% increase from 2019, according to a new data brief from the Department of Health and Human Servic ...
Health plans are lobbying the Trump administration to scrap a proposal dating from the final days of the Biden administration that would require Medicare and Medicaid to cover anti-obesity drugs, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results